OP 3.7 – 00099 Cohort-specific Adaptation of the Intact Proviral DNA Assay (IPDA) to HIV-1 subtypes A1, D, and recombinants

• S.N. Gowanlock,
• D.C. Copertino,
• Pragya Khadka,
• R. Brad Jones,
• Jingo Kasule,
• T. Kityamuweesi,
• P. Buule,
• S. Reynolds,
• T. Quinn,
• A.D. Redd,
• Z.L. Brumme,
• J. Prodger,
• G.Q. Lee

Affiliations

S.N. Gowanlock

Department of Microbiology and Immunology, Western University, London, ON, Canada

D.C. Copertino

Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA

Pragya Khadka

Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA

R. Brad Jones

Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA

Jingo Kasule

Rakai Health Sciences Program, Kalisizo, Uganda

T. Kityamuweesi

Rakai Health Sciences Program, Kalisizo, Uganda

P. Buule

Rakai Health Sciences Program, Kalisizo, Uganda

S. Reynolds

Rakai Health Sciences Program, Kalisizo, Uganda; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

T. Quinn

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

A.D. Redd

Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Z.L. Brumme

Simon Fraser University, Burnaby, BC, Canada; BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada

J. Prodger

Department of Microbiology and Immunology, Western University, London, ON, Canada

G.Q. Lee

Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA